Anti-TNF, a magic bullet in cancer immunotherapy?

Immune checkpoint blockers (ICB) have revolutionized cancer therapy. However, complete response is observed in a minority of patients and most patients develop immune-related adverse events (irAEs). These include colitis, which can be treated with anti-tumor necrosis factor (TNF) antibodies such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Montfort, Anne, Dufau, Carine, Colacios, Céline, Andrieu-Abadie, Nathalie, Levade, Thierry, Filleron, Thomas, Delord, Jean-Pierre, Ayyoub, Maha, Meyer, Nicolas, Ségui, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857159/
https://www.ncbi.nlm.nih.gov/pubmed/31727152
http://dx.doi.org/10.1186/s40425-019-0802-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857159/
https://www.ncbi.nlm.nih.gov/pubmed/31727152
http://dx.doi.org/10.1186/s40425-019-0802-y

Ejemplares similares